402 related articles for article (PubMed ID: 19765180)
1. Neuronal cell replacement in Parkinson's disease.
Hedlund E; Perlmann T
J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
[TBL] [Abstract][Full Text] [Related]
2. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
4. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
5. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
6. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
7. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
8. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
9. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
11. Grafted dopamine neurons: Morphology, neurochemistry, and electrophysiology.
Strömberg I; Bickford P; Gerhardt GA
Prog Neurobiol; 2010 Feb; 90(2):190-7. PubMed ID: 19853009
[TBL] [Abstract][Full Text] [Related]
12. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
Wang S; Qi XJ; Han D
Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
[TBL] [Abstract][Full Text] [Related]
13. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
15. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of Parkinson's disease].
Maciaczyk J; Swietaszczyk C; Kasprzak HA
Przegl Lek; 2004; 61(12):1383-8. PubMed ID: 15850334
[TBL] [Abstract][Full Text] [Related]
17. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
Linazasoro G
Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
[TBL] [Abstract][Full Text] [Related]
18. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
Lindvall O; Kokaia Z
Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
[TBL] [Abstract][Full Text] [Related]
19. Neural stem cells and Parkinson's disease.
Storch A; Schwarz J
J Neurol; 2002 Oct; 249 Suppl 3():III/30-2. PubMed ID: 12522569
[TBL] [Abstract][Full Text] [Related]
20. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]